28 July 2023 - It is time for the public to recognize and strongly support the authority of the US Centers for Medicare & Medicaid Services (CMS) to make reasonable and necessary coverage decisions for Medicare beneficiaries and for Congress to codify that authority and specifically include drug and device costs as part of the reasonable determination. 

At present, although CMS has authority to make reasonable and necessary coverage decisions, the standard for determining which medical products are reasonable and necessary is unclear and subject to political haggling.

Read JAMA Internal Medicine article